TRI/ML is conlrntndealed InCNS rfoprosson fromdrugs, inuw presence o-' ©vidcncc mpatwots hypersensitive to phenothlaanos or amitriptyline ii should not txt used dinng following myoc-ofdiai infarction conlaining perphenazine and amilriptyline HCI helps treat both depression and moderate anxiety an antidepressant alone may not be enougt D em u le n 1 /3 5 (ethynodiol diacetate i mg. ethinyl estradiol 35 meg) Where protection begins tor prodsn. which diMMWi rrpenrd x lhroinb<Srn&ot* ~*T. »»*Sr .-crd to monitor parwnti lorof^tvroptomf'^ljiy dariMi crnxdtc*: r i f A w i . l ouworbr diKor-sr.ucd whenapproprUtr ?itue M««dpMag ptgt for abrief tommaryot prescribing information The OC innovator SEARLE 1 1 Ct/fwrSearle. Agency: Medicus. CD: Michael Marisso. AD: Caroline Cooper. Copy: Steven Gold. 2 Client: Merck. Agency: Kallir, Philips, Ross. AD: John Geryak. (1982).
RkJQdWJsaXNoZXIy NDMwNDAx